New program for healthcare providers brings
treatment and prevention education and strategies to non-liver
experts
FAIRFIELD, N.J., July 11,
2024 /PRNewswire/ -- American Liver Foundation (ALF)
announces a new Project Echo program for healthcare providers that
will bring treatment and prevention best practices for nonalcoholic
fatty liver disease (NAFLD)* to non-liver experts. The Liver Health
ECHO Program is a virtual community of practice developed to equip
healthcare providers with the necessary skills to treat and prevent
NAFLD among their patients. Within this network, participants will
gain support and mentorship, enhance their skills, and connect with
leaders in the field all at no cost.
New Liver Health Project Echo for HCPs will
bring treatment and prevention best practices of NAFLD to non-liver
experts
"Diagnosing nonalcoholic fatty liver disease early is crucial to
a patient's long-term success and providing our non-liver partners
with the education, tools and insight they need to recognize the
early warning signs and help prevent progression is key,"
said Emmanuel Thomas, MD, PhD,
FAASLD, ALF Board Chair and Associate Professor at University of Miami School of Medicine and member
of the Sylvester Comprehensive Cancer Center and the Schiff Center
for Liver Diseases at University of
Miami.
The Project Echo sessions will be held monthly starting in
August and will run for five months. This program will provide
structured support in treating NAFLD with practical prevention
strategies, mentorship from peers and experts in the field,
collaborative problem-solving and sharing of resources, and
connection with other primary care providers and allied health
professionals across the United
States.
- Session #1 – August
6th, 12PM to 1PM
ET--NAFLD 101: An Overview of the Condition
- Session #2 –September
3rd, 12PM to 1PM
ET--NAFLD Screening & Testing: Latest Advancements in
Diagnostic Options
- Session #3 – October
1st, 12PM to 1PM
ET--NAFLD Staging & Treatment: Effectively Treat &
Manage Each Stage of the Condition
- Session #4 –November
5th, 12PM to 1PM
ET--NAFLD Prevention: Utilize Health Education to Improve
Patient Health
- Session #5 – December
3rd, 12PM to 1PM
ET--The Future of NAFLD: Emerging Issues &
Resources
Registration is available free of charge. Learn more at
liverfoundation.org/projectecho.
*The nomenclature for nonalcoholic fatty liver disease (NAFLD)
has recently changed to metabolic dysfunction associated steatotic
liver disease (MASLD). Nonalcoholic steatohepatitis (NASH) has been
renamed to metabolic dysfunction associated steatohepatitis (MASH).
Fatty liver disease is now called steatotic liver disease. Learn
more about the nomenclature changes in this video:
https://liverfoundation.org/resource-center/videos/new-nomenclature-for-fatty-liver-disease/.
About the American Liver Foundation
American Liver
Foundation (ALF) is a national community of patients, caregivers
and medical professionals dedicated to helping people improve their
liver health. Providing guidance and life-saving resources, we are
a beacon for the 100 million Americans affected by liver disease.
We advocate for patients and families, fund medical research and
educate the public about liver wellness and disease prevention. We
bring people together through our educational programs and events
and create a network of support that lasts a lifetime. ALF is the
largest organization focused on all liver diseases and the trusted
voice for patients and families living with liver disease. For more
information visit www.liverfoundation.org or call: 1 800 GO LIVER
(800-465-4837).
Contact: Julie
Kimbrough
JKimbrough@liverfoundation.org
Direct dial: 646-737-9409
Facebook
Twitter
LinkedIn
YouTube
Instagram
View original content to download
multimedia:https://www.prnewswire.com/news-releases/american-liver-foundation-announces-project-echo-for-liver-disease-302194298.html
SOURCE American Liver Foundation